Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
AstraZeneca
AstraZeneca
Eli Lilly and Company
Qilu Pharmaceutical Co., Ltd.
Eli Lilly and Company
Merck Sharp & Dohme LLC
Incyte Corporation
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Incyte Corporation
Critical Outcome Technologies Inc.